Loading...

Home
ETF
PROK

PROK

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

PROK News

Avant Technologies Drives 67.5% Market Share in Cell Therapy Manufacturing

Dec 16 2025PRnewswire

Avant Technologies Drives 67.5% Market Share in Cell Therapy Manufacturing

Dec 16 2025Newsfilter

PROKIDNEY CORP. Reports Smaller Q3 Loss, Surpassing Expectations

Nov 11 2025NASDAQ.COM

ProKidney Announces Financial Results for Q3 2025 Along with Regulatory and Clinical Updates

Nov 10 2025Newsfilter

ProKidney Unveils Comprehensive Findings from Phase 2 REGEN-007 Trial of Rilparencel at the 2025 American Society of Nephrology Kidney Week

Nov 06 2025Newsfilter

ProKidney Reveals Two Abstracts Chosen for Presentation at the 2025 Kidney Week of the American Society of Nephrology

Oct 20 2025Newsfilter

ProKidney Corp. (PROK) Shares Insights at Citi's Biopharma Back to School Conference Transcript

Sep 03 2025Newsfilter

ProKidney to Attend Citi Biopharma Back to School Conference and Morgan Stanley Global Healthcare Conference

Aug 27 2025Newsfilter

Forecast: Chamath Palihapitiya's $250 Million SPAC May Develop the Next Palantir for the U.S. Energy Grid

Aug 24 2025NASDAQ.COM

Chamath Palihapitiya Reenters SPAC Market: Previous 18 Deals Show Average Loss of 14%

Aug 19 2025Benzinga

Palihapitiya cautions against emotional reactions in the casino while introducing a new SPAC.

Aug 19 2025MarketWatch

ProKidney Reports 78 Percent Gain in Q2

Aug 13 2025NASDAQ.COM

JP Morgan Maintains a Neutral Stance on ProKidney Corp. (PROK)

Jul 20 2025Yahoo Finance

ProKidney Secures FDA Alignment On Accelerated Approval Pathway For Rilparencel

Jul 15 2025NASDAQ.COM

Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Jul 15 2025Benzinga

ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel

Jul 15 2025Newsfilter